Two steps forward and one step back

Nat Rev Clin Oncol. 2019 Feb;16(2):69-70. doi: 10.1038/s41571-018-0154-4.
No abstract available

MeSH terms

  • Chemoradiotherapy, Adjuvant
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Docetaxel / therapeutic use*
  • Epirubicin / therapeutic use*
  • Humans
  • Perioperative Care
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / genetics*
  • Standard of Care
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / surgery
  • Treatment Outcome

Substances

  • Docetaxel
  • Epirubicin
  • ERBB2 protein, human
  • Receptor, ErbB-2